Quick Overview: Declan Murphy, FRACS, FRCS, Peter MacCallum Cancer Centre, Melbourne, Australia, explains the rationale for Assessing the number needed to treat for an In this video interview, Dr. Lestingi discusses the randomised phase-three trial of
Skipping Extended Pelvic Lymph Node - Detailed Overview & Context
Declan Murphy, FRACS, FRCS, Peter MacCallum Cancer Centre, Melbourne, Australia, explains the rationale for Assessing the number needed to treat for an In this video interview, Dr. Lestingi discusses the randomised phase-three trial of Prof. Mattei and his colleagues demonstrate the "monoblock" technique for PCRI's Executive Director, Mark Scholz, MD, distinguishes the High-Indigo stage of prostate cancer as relapsed disease with ... In this 14-minute presentation, he addresses
Dr. Geoff Gotto, a Urologist from the Southern Alberta Institute of Urology, spoke on the therapeutic role of Laparoscopic Extended Pelvic Lymph Node Dissection For Prostate Cancer We have been discussing a lot about the role of GU Cast is back after our summer break in Melbourne, with a cracking episode focussing on This video presents the latest findings from a randomized clinical trial comparing limited versus
